TEAM

The Oslo Cancer Cluster Management Team has significant industry experience and builds on a strong national and international network.

Ketil Widerberg

Ketil Widerberg

General Manager

E-mail: kw@oslocancercluster.no
Mobile: + 47 915 77 990

Ketil F. Widerberg, MBA, is General Manager of Oslo Cancer Cluster. He builds on a long experience in realizing new projects within oncology in the biopharmaceutical company Photocure ASA in collaboration with academic institutions and international commercial partners.

Ketil has a broad operational experience ranging from explorative project management to being responsible for business development.

Widerberg’s educational background spans from preclinical medical school to management studies. He also holds a MBA from the University of Cambridge.

Jutta Heix

Jutta Heix

Head of International Affairs

E-mail: jh@oslocancercluster.no
Mobile: + 47 941 63 089

Jutta Heix, Head of International Affairs, is a life science professional with more than 20 years of industry experience. She holds a PhD from the University of Heidelberg / German Cancer Research Center and worked in different Business Development positions in international pharma and biotech companies prior to joining Oslo Cancer Cluster.

Jutta is responsible for the cluster’s international collaboration, initiatives and events and provides innovation and business development support to Oslo Cancer Cluster and Incubator members. As a Co-Founder of the Norwegian Program, she is a member of the SPARK Norway Management Team and Program Advisor for the NLSDays.

D.B.R.K Gupta Udatha

D.B.R.K Gupta Udatha

Director (Digital and EU)

E-mail: gu@oslocancercluster.no
Mobile: + 47 455 34 627

Gupta Udatha is Director at Oslo Cancer Cluster with a focus on Digital and EU initiatives. Gupta Udatha received his PhD from Chalmers University of Technology - Sweden. He has led the development of multi-national collaborations and coordinated research groups in academia & industry.

Dr. Udatha has 12 years’ of R&D experience in the fields of bioinformatics, systems biology and big data analytics of biopharmaceutical data. He is also an entrepreneur and supporter of open-access publishing.

Charlotte Wu Homme

Charlotte Wu Homme

Head of Membership & Events

E-mail: cwh@oslocancercluster.no

Charlotte Wu Homme is responsible for Membership & Events for Oslo Cancer Cluster. This includes R&D network meetings, symposiums, and other initiatives for cluster members.

She has served different international organizations while posted in the U.S, Norway, and throughout Asia. These organizations include: The Economist, The World Bank, and Johns Hopkins University. Charlotte Homme attained her Master of Science in Project Management from The George Washington University.

Margrethe Harboe

Margrethe Harboe

Membership & Events Coordinator

E-mail: mh@oslocancercluster.no

Margrethe Harboe is a project management professional with extensive experience working within membership activities and the delivery of tailored meetings and events.

Margrethe graduated from The New School (BBA, Parsons), New York, where she specialized in strategic design and management for businesses. She has supported several international membership organizations in New York and Oslo.

Bente Prestegård

Bente Prestegård

Project Manager

E-mail: bp@oslocancercluster.no
Mobile: + 47 413 08 175

Bente Prestegård is Project Manager in Oslo Cancer Cluster, where she mainly works on the educational agreement with Ullern Upper Secondary School and oncology clinical studies.

Bente has a background from business administration, as a pharmaceutical sales representative and she has worked with collaboration agreements between Oslo University Hospital and the pharmaceutical industry.

Thomas Andersson

Thomas Andersson

Senior Advisor Business Development

E-mail: ta@occincubator.com
Mobile: +46 70 538 93 78

Thomas Andersson is Senior Advisor Business Development at Oslo Cancer Cluster and Oslo Cancer Cluster Incubator.

Thomas holds a Ph.D. in biophysics from Lund University and has more than 30 years of experience from establishing, operating and funding start-ups in the life science field.

Eva S. Dugstad

Eva S. Dugstad

Special Advisor

E-mail: eva@radforsk.no
Mobile: +47 959 63 904

Eva S. Dugstad started in the position as Director for Business Development in the Norwegian Radium Hospital Research Foundation in 2017, and is also serving as a special advisor for Oslo Cancer Cluster.

She holds a Cand. Pharm. degree from the University of Oslo. Her previous appointments include the President and Exec.Vice President at the Institute for Energy Technology (IFE) and Research Director for Sector Nuclear Technology and Physics at IFE, where radiopharmaceuticals was a priority.

Wenche Gerhardsen

Wenche Gerhardsen

Head of Communications

E-mail: wg@oslocancercluster.no
Mobile: + 47 928 79 842

Wenche Gerhardsen is responsible for internal and external communications in the cluster and incubator, including e.g. our webpages, social media, media-relations and marketing.

She has previously worked at The Norwegian Defence Research Establishment (FFI) as Senior Advisor and Communications Advisor and she has a background as a news- and science journalist. Her master’s degree is in political science. You can read more about Wenche’s background at LinkedIn.

Sofia Lindén

Sofia Lindén

Communications Advisor

E-mail: sl@oslocancercluster.no
Mobile: + 47 405 31 400

Sofia Lindén is responsible for producing the content for digital communications in the cluster, including articles, photographs and videos for the websites and social media platforms.

She has previously worked at the Nordic publishing company Orage as Swedish Print Editor and Digital Project Manager. She also holds a master degree in International Journalism from City University London. Find out more about Sofia by visiting her LinkedIn.

Eirin Bragstad

Eirin Bragstad

Main Accountant

E-mail: eb@oslocancercluster.no
Mobile: + 47 414 89 648

Eirin Bragstad is Main Accountant of Oslo Cancer Cluster, Oslo Cancer Cluster Incubator and the Norwegian Radium Hospital Research Foundation.